What is it about?

In pulmonary medicine, there has been a long-standing need to treat diseases associated with mucus accumulation in the lungs. This study supports the need for novel reducing agents and provides unique insights into new mucolytic agents as inhaled therapies to treat lung disease.

Featured Image

Read the Original

This page is a summary of: An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases, American Review of Respiratory Disease, January 2019, American Thoracic Society,
DOI: 10.1164/rccm.201802-0245oc.
You can read the full text:

Read

Contributors

The following have contributed to this page